title: Utilization of herpes simplex PCR assays for cerebrospinal fluid in a pediatric health care setting.
abstract: An assessment was made of the utilization and impact of a diagnostic polymerase chain reaction (PCR) assay for the diagnosis of herpes simplex viruses (HSV) 1 and 2 in cerebrospinal fluid of children who attended a Canadian pediatric referral centre. One hundred and three assays were performed on specimens from 103 patients during the period August 1997 to September 1998. Patient ages ranged from newborn to 16 years. Indications for HSV PCR included seizures with or without fever (56.3%), aseptic meningitis (16.5%), and encephalopathy with or without fever (10.7%). Only 2 of 103 (1.9%) assays were positive, including one each for HSV1 and HSV2. Control specimens that were seeded with virus indicated inhibition for 24.3, 8.8, and 6.8% of assays for HSV1, HSV2, and both HSV1 and HSV2, respectively. The mean turn-around time for HSV PCR was 2.5 days, and 90.3% were completed in less than 5 days. Acyclovir was administered to 78.6% of the patients overall; the results of the HSV PCR impacted on the treatment courses for 36 individuals. Nevertheless, 16.5% of patients continued to receive extended courses of antiviral therapy despite negative HSV PCR assays. Although it is desirable to decrease the frequency of PCR inhibitions and to further decrease the interval to assay completion, HSV PCR does have a significant impact on antiviral use in this setting.
authors.affiliation: Department of Pathology and Laboratory Medicine, The University of British of Columbia, Vancouver, Canada. ncimolai@cw.bc.ca
authors.forename: N
authors.initials: N
authors.lastname: Cimolai
authors.forename: E E
authors.initials: EE
authors.lastname: Thomas
authors.forename: R
authors.initials: R
authors.lastname: Tan
authors.forename: A
authors.initials: A
authors.lastname: Hill
mesh_terms: D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D020803:Encephalitis, Herpes Simplex / Q000134:cerebrospinal fluid*; D005260:Female; D018259:Herpesvirus 1, Human / Q000235:genetics / Q000302:isolation & purification*; D018258:Herpesvirus 2, Human / Q000235:genetics / Q000302:isolation & purification*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D016133:Polymerase Chain Reaction; D012017:Referral and Consultation; D012189:Retrospective Studies